BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23019409)

  • 1. Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) mice.
    Rao CV; Mohammed A; Janakiram NB; Li Q; Ritchie RL; Lightfoot S; Vibhudutta A; Steele VE
    Neoplasia; 2012 Sep; 14(9):778-87. PubMed ID: 23019409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice.
    Mohammed A; Janakiram NB; Brewer M; Duff A; Lightfoot S; Brush RS; Anderson RE; Rao CV
    Neoplasia; 2012 Dec; 14(12):1249-59. PubMed ID: 23308056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model.
    Mohammed A; Janakiram NB; Li Q; Madka V; Ely M; Lightfoot S; Crawford H; Steele VE; Rao CV
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1417-26. PubMed ID: 21084261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice.
    Mohammed A; Qian L; Janakiram NB; Lightfoot S; Steele VE; Rao CV
    Int J Cancer; 2012 Oct; 131(8):1951-62. PubMed ID: 22287227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice.
    Bai H; Li H; Zhang W; Matkowskyj KA; Liao J; Srivastava SK; Yang GY
    Carcinogenesis; 2011 Nov; 32(11):1689-96. PubMed ID: 21859833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.
    Keenan BP; Saenger Y; Kafrouni MI; Leubner A; Lauer P; Maitra A; Rucki AA; Gunderson AJ; Coussens LM; Brockstedt DG; Dubensky TW; Hassan R; Armstrong TD; Jaffee EM
    Gastroenterology; 2014 Jun; 146(7):1784-94.e6. PubMed ID: 24607504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets.
    Rao CV; Reddy BS; Steele VE; Wang CX; Liu X; Ouyang N; Patlolla JM; Simi B; Kopelovich L; Rigas B
    Mol Cancer Ther; 2006 Jun; 5(6):1530-8. PubMed ID: 16818512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed progression of pancreatic intraepithelial neoplasia in a conditional Kras(G12D) mouse model by a selective cyclooxygenase-2 inhibitor.
    Funahashi H; Satake M; Dawson D; Huynh NA; Reber HA; Hines OJ; Eibl G
    Cancer Res; 2007 Aug; 67(15):7068-71. PubMed ID: 17652141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
    Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
    Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cholecystokinin-2 receptor for pancreatic cancer chemoprevention.
    Mohammed A; Janakiram NB; Suen C; Stratton N; Lightfoot S; Singh A; Pathuri G; Ritchie R; Madka V; Rao CV
    Mol Carcinog; 2019 Oct; 58(10):1908-1918. PubMed ID: 31313401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged survival and delayed progression of pancreatic intraepithelial neoplasia in LSL-KrasG12D/+;Pdx-1-Cre mice by vitamin E δ-tocotrienol.
    Husain K; Centeno BA; Chen DT; Fulp WJ; Perez M; Zhang Lee G; Luetteke N; Hingorani SR; Sebti SM; Malafa MP
    Carcinogenesis; 2013 Apr; 34(4):858-63. PubMed ID: 23302291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice.
    Philip B; Roland CL; Daniluk J; Liu Y; Chatterjee D; Gomez SB; Ji B; Huang H; Wang H; Fleming JB; Logsdon CD; Cruz-Monserrate Z
    Gastroenterology; 2013 Dec; 145(6):1449-58. PubMed ID: 23958541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice.
    Liao J; Chung YT; Yang AL; Zhang M; Li H; Zhang W; Yan L; Yang GY
    Mol Carcinog; 2013 Sep; 52(9):739-50. PubMed ID: 22549877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53.
    Zhang Z; Li H; Deng Y; Schuck K; Raulefs S; Maeritz N; Yu Y; Hechler T; Pahl A; Fernández-Sáiz V; Wan Y; Wang G; Engleitner T; Öllinger R; Rad R; Reichert M; Diakopoulos KN; Weber V; Li J; Shen S; Zou X; Kleeff J; Mihaljevic A; Michalski CW; Algül H; Friess H; Kong B
    Gastroenterology; 2021 Nov; 161(5):1601-1614.e23. PubMed ID: 34303658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.
    Liao J; Hwang SH; Li H; Liu JY; Hammock BD; Yang GY
    Anticancer Res; 2016 Jan; 36(1):27-37. PubMed ID: 26722025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer.
    DiNorcia J; Lee MK; Moroziewicz DN; Winner M; Suman P; Bao F; Remotti HE; Zou YS; Yan SF; Qiu W; Su GH; Schmidt AM; Allendorf JD
    J Gastrointest Surg; 2012 Jan; 16(1):104-12; discussion 112. PubMed ID: 22052106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling.
    Mohammed A; Janakiram NB; Madka V; Ritchie RL; Brewer M; Biddick L; Patlolla JM; Sadeghi M; Lightfoot S; Steele VE; Rao CV
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1198-209. PubMed ID: 25248858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of
    Saeki K; Qiu W; Friedman RA; Pan S; Lu J; Ichimiya S; Chio IIC; Shawber CJ; Kitajewski J; Hu J; Su GH
    Cancer Res Commun; 2022 Dec; 2(12):1601-1616. PubMed ID: 36970723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model.
    Ouyang N; Williams JL; Tsioulias GJ; Gao J; Iatropoulos MJ; Kopelovich L; Kashfi K; Rigas B
    Cancer Res; 2006 Apr; 66(8):4503-11. PubMed ID: 16618778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.